General Information of the Compound
Compound ID
CP0139457
Compound Name
US10479788, Example 182
    Show/Hide
Synonyms
BDBM241338
BOS172722
CHEMBL3924132
SCHEMBL15515080
SGWLRDAOCLITOM-UHFFFAOYSA-N
US9409907, 182
    Show/Hide
Structure
Formula
C24H30N8O
Molecular Weight
446.559
Canonical SMILES
CCOc1cc(ccc1Nc1ncc2cc(C)nc(NCC(C)(C)C)c2n1)-c1nncn1C
    Show/Hide
InChI
InChI=1S/C24H30N8O/c1-7-33-19-11-16(22-31-27-14-32(22)6)8-9-18(19)29-23-25-12-17-10-15(2)28-21(20(17)30-23)26-13-24(3,4)5/h8-12,14H,7,13H2,1-6H3,(H,26,28)(H,25,29,30)
    Show/Hide
InChIKey
SGWLRDAOCLITOM-UHFFFAOYSA-N
Physicochemical Property
logP
4.72902
Rotatable Bonds
7
Heavy Atom Count
33
Polar Areas
102.67
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
9
Complexity
33

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 73386890
ChEMBL ID
CHEMBL3924132
DrugBank ID
DB15498
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01348, Dual specificity protein kinase TTK
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000067 HCT 116 Homo sapiens (Human)  1
1
IC50 = 63 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 3 nM
Clinical Information about the Compound
Drug 1 ( BOS172722 )
Drug Name BOS172722
Company Boston Pharmaceuticals Cambridge, MA
Indication
Solid tumour/cancer
Phase 1
Target(s)
Dual specificity protein kinase TTK (MPS1)
Inhibitor